rs3136435

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000506.5(F2):​c.316+36G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0833 in 1,612,902 control chromosomes in the GnomAD database, including 8,822 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2948 hom., cov: 32)
Exomes 𝑓: 0.077 ( 5874 hom. )

Consequence

F2
NM_000506.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0760

Publications

13 publications found
Variant links:
Genes affected
F2 (HGNC:3535): (coagulation factor II, thrombin) This gene encodes the prothrombin protein (also known as coagulation factor II). This protein is proteolytically cleaved in multiple steps to form the activated serine protease thrombin. The activated thrombin enzyme plays an important role in thrombosis and hemostasis by converting fibrinogen to fibrin during blood clot formation, by stimulating platelet aggregation, and by activating additional coagulation factors. Thrombin also plays a role in cell proliferation, tissue repair, and angiogenesis as well as maintaining vascular integrity during development and postnatal life. Peptides derived from the C-terminus of this protein have antimicrobial activity against E. coli and P. aeruginosa. Mutations in this gene lead to various forms of thrombosis and dysprothrombinemia. Rapid increases in cytokine levels following coronavirus infections can dysregulate the coagulation cascade and produce thrombosis, compromised blood supply, and organ failure. [provided by RefSeq, May 2020]
F2 Gene-Disease associations (from GenCC):
  • thrombophilia due to thrombin defect
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • congenital prothrombin deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 11-46720876-G-A is Benign according to our data. Variant chr11-46720876-G-A is described in ClinVar as Benign. ClinVar VariationId is 1290658.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.351 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F2NM_000506.5 linkc.316+36G>A intron_variant Intron 4 of 13 ENST00000311907.10 NP_000497.1 P00734

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F2ENST00000311907.10 linkc.316+36G>A intron_variant Intron 4 of 13 1 NM_000506.5 ENSP00000308541.5 P00734
F2ENST00000530231.5 linkc.316+36G>A intron_variant Intron 4 of 13 5 ENSP00000433907.1 E9PIT3
F2ENST00000442468.1 linkc.286+36G>A intron_variant Intron 4 of 7 3 ENSP00000387413.1 C9JV37

Frequencies

GnomAD3 genomes
AF:
0.148
AC:
22541
AN:
151996
Hom.:
2937
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.356
Gnomad AMI
AF:
0.0954
Gnomad AMR
AF:
0.0769
Gnomad ASJ
AF:
0.0664
Gnomad EAS
AF:
0.101
Gnomad SAS
AF:
0.0561
Gnomad FIN
AF:
0.0473
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.0696
Gnomad OTH
AF:
0.133
GnomAD2 exomes
AF:
0.0842
AC:
21029
AN:
249896
AF XY:
0.0789
show subpopulations
Gnomad AFR exome
AF:
0.361
Gnomad AMR exome
AF:
0.0441
Gnomad ASJ exome
AF:
0.0640
Gnomad EAS exome
AF:
0.0959
Gnomad FIN exome
AF:
0.0456
Gnomad NFE exome
AF:
0.0705
Gnomad OTH exome
AF:
0.0760
GnomAD4 exome
AF:
0.0765
AC:
111787
AN:
1460788
Hom.:
5874
Cov.:
31
AF XY:
0.0752
AC XY:
54668
AN XY:
726662
show subpopulations
African (AFR)
AF:
0.369
AC:
12351
AN:
33468
American (AMR)
AF:
0.0477
AC:
2134
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0664
AC:
1736
AN:
26128
East Asian (EAS)
AF:
0.0870
AC:
3453
AN:
39694
South Asian (SAS)
AF:
0.0653
AC:
5628
AN:
86244
European-Finnish (FIN)
AF:
0.0467
AC:
2469
AN:
52920
Middle Eastern (MID)
AF:
0.0924
AC:
533
AN:
5768
European-Non Finnish (NFE)
AF:
0.0703
AC:
78111
AN:
1111464
Other (OTH)
AF:
0.0890
AC:
5372
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
5525
11050
16574
22099
27624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3080
6160
9240
12320
15400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.148
AC:
22582
AN:
152114
Hom.:
2948
Cov.:
32
AF XY:
0.145
AC XY:
10799
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.356
AC:
14758
AN:
41434
American (AMR)
AF:
0.0768
AC:
1173
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0664
AC:
230
AN:
3466
East Asian (EAS)
AF:
0.101
AC:
523
AN:
5172
South Asian (SAS)
AF:
0.0555
AC:
268
AN:
4830
European-Finnish (FIN)
AF:
0.0473
AC:
502
AN:
10608
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.0696
AC:
4731
AN:
68006
Other (OTH)
AF:
0.131
AC:
276
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
841
1682
2522
3363
4204
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0941
Hom.:
1663
Bravo
AF:
0.159
Asia WGS
AF:
0.101
AC:
352
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
2.7
DANN
Benign
0.59
PhyloP100
-0.076
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3136435; hg19: chr11-46742426; COSMIC: COSV61317638; COSMIC: COSV61317638; API